[Clinicopathological characteristics and prognosis of malignant pleural mesothelioma]

Wen-hui Chen1, Xue-li Zhang1, Hua-ping Dai1

  • 1Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

Abstract

Insights

Malignant pleural mesothelioma presents with nonspecific symptoms, but medical thoracoscopy aids early diagnosis. Chemotherapy with pemetrexed and cisplatin/carboplatin can improve survival for this aggressive cancer.

Area of Science:

  • Pulmonology
  • Oncology
  • Pathology

Background:

  • Malignant pleural mesothelioma is a rare but aggressive cancer.
  • Early diagnosis and effective treatment strategies are crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the clinicopathological features of malignant pleural mesothelioma.
  • To evaluate the diagnostic utility of medical thoracoscopy and immunohistochemistry.
  • To assess the prognostic factors and treatment efficacy for malignant pleural mesothelioma.

Main Methods:

  • Retrospective analysis of 30 patients diagnosed with malignant pleural mesothelioma.
  • Review of clinical, radiological, endoscopic, and histopathological data.
  • Evaluation of immunohistochemical markers (calretinin, MC, D2-40) and survival status.

Main Results:

  • Common symptoms include dyspnea and chest pain; radiological findings often show pleural effusions and thickening.
  • Medical thoracoscopy facilitated diagnosis in 25 out of 30 cases.
  • Epithelial type was most common (24 cases), with positive rates for calretinin, MC, and D2-40.
  • Patients receiving chemotherapy (pemetrexed and cisplatin/carboplatin) or pleurectomy showed prolonged survival.

Conclusions:

  • Malignant pleural mesothelioma has nonspecific clinical manifestations, underscoring the importance of medical thoracoscopy for early diagnosis.
  • Immunohistochemistry, particularly using calretinin, MC, and D2-40, is vital for pathological confirmation.
  • The disease has a poor prognosis, but combination chemotherapy with pemetrexed and cisplatin/carboplatin or surgical intervention may extend survival.

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
1.1K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.4K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
6.3K